Immunotherapy

Advertisement

Advertisement

Gunter von Minckwitz, MD, on HER2+ Breast Cancer: Results From the APHINITY Trial

Cristina Saura, MD, on Choosing Neoadjuvant Treatment for Patients With Early Breast Cancer

G. Thomas Budd, MD, on Choosing Neoadjuvant Treatment for Patients With Early Breast Cancer

Recent

Phase II Durvalumab Trial in Resistant Head and Neck Cancer

Early Results of Phase I Study of CAR T-Cell Therapy in Multiple Myeloma

Novel Four-Drug Combination Therapy for Newly Diagnosed Multiple Myeloma

Clinical Trial of Personalized Vaccine in Kidney Cancer Commences

Published

Medical Literature

Study of Combination Immune Checkpoint Blockade in Stage III Melanoma Halted

Neoadjuvant Pembrolizumab Before Surgery in Muscle-Invasive Bladder Carcinoma

Pembrolizumab Plus Chemotherapy in Metastatic Squamous NSCLC

Combination Immunotherapy in First-Line Treatment of Advanced Kidney Cancer

Ongoing

Immune Checkpoint Inhibitors in Lung Cancer: No Longer the Road Less Traveled?

Immunotherapy for cSCC: How, Why, and When (login required)

Stage III NSCLC: Practical Application of Immune Checkpoint Inhibition After Chemoradiotherapy

JADPRO Regional Lectures: Clinical Management of Novel Therapies for Hematologic Malignancies: Targeted Therapies, CAR-T, and Beyond

Available

Clinical Trials

ClinicalTrials.gov Immunotherapy

Cancer Research Institute Immunotherapy Clinical Trials

Immunotherapy Clinical Trials at Fred Hutch Cancer Research Center

Center for Immunotherapy Clinical Research Trials

Sections

NCCN Resources

Copyright © 2018 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.